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ABSTRACT
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by deterioration of the brain functions 
that result in impairment of memory, cognition and behavioural functions. Oxidative stress is well known to be one of the 
causative factors for AD. Thus this disease is potentially modulated by natural antioxidants such as vitamin E. The aim 
of this study was to evaluate the effect of tocotrienol-rich fraction (TRF) supplementation on antioxidant enzymes and 
DNA damage using APPswe/PS1dE9 transgenic mouse model of AD. Animals were supplemented with TRF (200 mg/kg) 
or alpha-tocopherol (αT) (200 mg/kg) for six months starting from nine months old. We found that superoxide dismutase 
(SOD) activity in AD mouse was decreased by supplementation of TRF and αT as compared with AD control mouse with no 
significant differences in glutathione peroxidise (GPx) activity in all groups. TRF supplementation significantly increased 
catalase (CAT) activity. The level of DNA damage of AD mouse shows significant decrease with supplementation of TRF 
and αT. In conclusion, TRF was able to modulate antioxidant enzymes activity and decreased the level of DNA damage 
of AD transgenic mouse model.
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ABSTRAK
Penyakit Alzheimer (AD) adalah gangguan progresif neurodegeneratif yang boleh dicirikan dengan kemerosotan fungsi 
otak yang mengakibatkan kerosakan ingatan, kognitif dan fungsi tingkah laku. Tekanan oksidatif terkenal sebagai salah 
satu faktor penyebab AD. Oleh itu penyakit ini berpotensi dimodulasikan oleh antioksidan semula jadi seperti vitamin E. 
Kajian ini bertujuan menilai kesan suplementasi fraksi kaya tokotrienol (TRF) ke atas enzim antioksidan dan kerosakan 
DNA menggunakan APPswe/PS1dE9 model mencit transgenik AD. Model haiwan ini telah diberi suplementasi TRF (200 
mg/kg) atau αT (200 mg/kg) selama enam bulan dari usia sembilan bulan. Keputusan menunjukkan aktiviti SOD menurun 
pada mencit AD yang telah disuplementasi dengan TRF dan αT berbanding dengan mencit AD kawalan. Tiada perbezaan 
signifikan dalam aktiviti GPx dalam semua kumpulan. Manakala mencit AD yang diberi suplementasi TRF menunjukkan 
peningkatan ketara dalam aktiviti CAT. Daripada segi kerosakan DNA, suplementasi TRF dan αT menunjukkan penurunan 
ketara pada mencit AD. Kesimpulannya, TRF berpotensi untuk memodulasi aktiviti enzim antioksidan dan mengurangkan 
tahap kerosakan DNA model mencit transgenik AD.
Kata kunci: Fraksi kaya tokotrienol; penyakit Alzheimer; status oksidatif
INTRODUCTION
Alzheimer’s disease (AD) is a chronic neurodegenerative 
disorder that is manifested by global brain deterioration 
leading to progressive impairments of intellectual, 
cognition, behaviour and memory (Grand et al. 2011). The 
prevalence of AD has increased significantly for the past 
recent years impacting the healthcare system worldwide 
(Alzheimer’s Disease International 2013). Oxidative stress 
has been strongly suggested to be one of the causative 
factors in AD. Oxidative stress is defined as an imbalance 
level of free radicals and antioxidant (Feng & Wang 2012; 
Moneim 2015). Brain is the most vulnerable tissue in the 
body to be targeted by the oxidative agents such as free 
radicals due to its high oxygen consumptions. Low level of 
antioxidants can lead to a cascade of oxidative events that 
further enhance the production of amyloid-β in AD brain 
(Butterfield et al. 2007; Smith et al. 2007). Previous studies 
have shown the association between oxidative stress and 
AD. Aβ peptide generated free radical peptides in a cell-free 
incubation (Hensley et al. 1994). Oxidative stress level was 
also found to be elevated in the hippocampus and cerebral 
cortex of AD mouse model (Lovell et al. 1995; Resende et 
al. 2008) and AD patients (De Leo et al. 1998; Resende et 
al. 2008; Rinaldi et al. 2003). Increased oxidative stress 
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in AD appeared to be due to increase production of free 
radicals level which leads to alteration of antioxidant 
enzymes activity and level including superoxide dismutase 
(SOD), glutathione peroxidase (GPx), catalase (CAT) and 
endogenous antioxidants, namely glutathione, vitamins 
A, C and E, and carotenoids (Chauhan & Chauhan 2006; 
Zhao & Zhao 2013).
 Vitamin E is classified into tocopherol and tocotrienol. 
Tocotrienols are structurally different from tocopherol 
by having three double bonds on their isoprenoid side 
chain instead of a saturated phytyl side chain (Sen et al. 
2006). Tocotrienols have been shown to have more potent 
anticancer (Yap et al. 2008) and neuroprotective (Sen et al. 
2000) properties. Different studies using mixtures of vitamin 
E, known as tocotrienol-rich fraction (TRF), is reported to 
possess high antioxidant contents (Chin et al. 2011; Taib 
et al. 2015), anticancer (Abdul Hafid et al. 2013; Hafid et 
al. 2010; Rahman et al. 2014; Srivastava & Gupta 2006; 
Zhang et al. 2015), and anti-ageing activities (Makpol et 
al. 2013, 2011). More recent findings have indicated that 
TRF significantly improved cognitive functions in aged rats 
(Nagapan et al. 2013; Taridi et al. 2014, 2011). Therefore 
the present work was aimed to evaluate the effect of TRF 
supplementation on blood antioxidant enzymes and DNA 
damage of APPswe/PS1dE9 transgenic mouse model of AD.
MATERIALS AND METHODS
CHEMICALS
TRF (Golden Tri™ E 70, cat. #SB12112670) was purchased 
from Sime Darby (Kuala Lumpur, Malaysia) which 
consisted of 24% α-tocopherol (αT), 27% α-tocotrienol 
(αT3), 4% β-tocotrienol (βT3), 32%  γ-tocotrienol (γT3) 
and 14% δ-tocotrienol (δT3) in every 1 gram of TRF. αT 
was purchased from Sigma-Aldrich (cat. #T3634; St. 
Louis, MO, USA) and vitamin E-stripped palm oil (also 
known as RBD Palm Olein IV 60) was supplied by the 
Malaysian Palm Oil Board (MPOB), Selangor, Malaysia. 
TRANSGENIC MICE
Wild type and double transgenic male mouse B6C3-Tg 
(APPswe, PS1dE9)85Dbo/Mmjax with C57BL/6J genetic 
background were purchased from The Jackson Laboratory 
(cat. #004462; Bar Harbor ME, USA). The AD mouse 
model expressed mutant amyloid precursor protein (Mo/
HuAPP659swe) and mutant presenilin 1 (PS1dE9) which 
were associated with early-onset of AD (Jankowsky et al. 
2001). All mice were placed in a specific-pathogen-free 
condition and maintained individually in polycarbonate 
cages on a 12:12 light-dark cycle with light started 
at 7:00 am and 24 h ventilation. All equipments and 
materials such as cages, corn cobs, food pellets and drink 
containers were sterilized using UV light and autoclaved 
before use. This study was approved by the UKM Animal 
Ethics Committee (UKMAEC, approval #FP/BIOK/2013/
ZURINAH/15-MAY/509-MAY-2013-MAY-2016) and all 
animal works were conducted according to the national 
and international guidelines.
GENOTYPING
The mice genotype was confirmed by PCR. Tissues were 
obtained from ear punch and DNA was extracted using 
Puregene Core Kit A (cat.#8367396; Qiagen, Hilden, 
Germany). DNA extraction was performed according 
to manufacturer’s protocol. Primer sequences were 
based on the study by Hong et al. (2013). APPswe: 
(forward) 5’-GACTGACCACTCGACCAGGTTCTG-3’ 
a n d  ( r e v e r s e ) 
5’-CTTGTAAGTTGGATTCTCATATCCG-3’; for PS1 
A: (forward) 5’-AATAGAGAACGGCAGGAGCA-3’ 
and (reverse) 5’-GCCATGAGGGCACTAATCAT-3’; 
a n d  f o r  P S 1  B  ( f o r w a r d ) 
5’-CCTCTTTGTGACTATGTGGACTGATGTCGG-3’ 
a n d  ( r e v e r s e )  5 ’ - 
GTGGATAACCCCTCCCCCAGCCTAGACC-3’. PCR 
mixture consisted of 10× PCR Buffer, 15 mM MgCl2, 
10 mMdNTPs mix, 5 U/μL AmpliTaq gold (all from 
Applied Biosystems, Waltham, MA, USA), 5 mM primer 
each and 10-20 ng DNA in a total volume of 25 μL. PCR 
amplification was performed in the iCycler Thermal 
Cycler (Bio-Rad, Hercules, CA, USA) with an initial 
denaturation at 95°C for 10 min, followed by 30 cycles 
of denaturation at 95°C for 30 s, annealing at 56°C for 30 
s and extension at 72°C for 1 min; and a final extension 
at 72°C for 8 min. PCR products were confirmed with 2% 
agarose gel electrophoresis.
SUPPLEMENTATION
Mice were divided into 4 different groups (n=8 per 
group): Wild type mouse; APPswe/PS1dE9 transgenic 
mouse without supplementation as control; APPswe/
PS1dE9 transgenic mouse supplemented with TRF; and 
APPswe/PS1dE9 transgenic mouse supplemented with 
αT. All mice received six months supplementation from 
nine months old. APPswe/PS1dE9 transgenic mouse 
were supplemented by oral gavage with TRF (200 mg/
kg) or αT (200 mg/kg), while the wild type and APPswe/
PS1dE9 transgenic mouse without supplementation were 
administered with distilled water. 
SAMPLES COLLECTION AND PREPARATION
Upon the completion of supplementation period, blood 
samples were collected through cardiac puncture using 
1 mL syringe and 25G needles that was readily coated 
with heparin. Blood was centrifuged and erythrocytes 
were collected. The erythrocytes were lysed with ice-cold 
HPLC-grade water. The erythrocyte lysate were centrifuged 
and the supernatant was collected and used for SOD, GPx 
and CAT assays.
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ANTIOXIDANT ENZYME ASSAYS
SOD activity was determined using Superoxide Dismutase 
Assay Kit (cat. #706002; Cayman Chemical Company, 
Ann Arbor, MI, USA). GPx activity was determined using 
Glutathione Peroxidase Assay Kit (cat. #703102; Cayman 
Chemical Company). CAT activity was determined using 
Catalase Assay Kit (cat. #707002; Cayman Chemical 
Company). All assays were performed according to the 
manufacturer’s protocol. Absorbance was determined using 
microplate reader (Infinite® 200 PRO and Magellan 7.0 Data 
Analysis Software, Tecan, Maennedorf, Switzerland).
COMET ASSAY
The comet assay was performed to measure the level of 
DNA strand breaks in cells. Fresh mice blood was obtained 
from the tail. The assay was conducted according to the 
method that was described previously (Singh et al. 1988). 
STATISTICAL ANALYSIS
Statistical analyses were performed using student’s 
unpaired t-tests for single comparisons. Differences were 
considered to be significant at p<0.05 level using GraphPad 
Prism® 5 (Version 5.01, GraphPad Software, Inc., USA).
RESULTS
Figure 1 shows the genotyping result for APPswe and 
PS1dE9 genes. Only mice with both APPswe and PS1dE9 
transgenes were used as transgenic mouse model of AD.
 The effect of TRF supplementation on transgenic 
mouse model of AD was assessed by measuring the 
activity of antioxidant enzymes in the erythrocyte and 
the level of DNA damage from the whole blood. SOD 
activity was significantly decreased (p<0.05) in AD mouse 
supplemented with TRF (113.97 ± 9.23 U/mL) and AD 
mouse supplemented with αT (125.38 ± 9.80 U/mL) when 
compared with non-supplemented AD mouse (181.03 ± 
11.42 U/mL) (Figure 2(a)). The activity of GPx showed no 
significant difference among all groups (Figure 2(b)). CAT 
activity was increased significantly (p<0.05) in AD mouse 
following TRF supplementation (10.55 ± 1.08 μmol/min/
mL) compared with wild type mouse (6.55 ± 1.08 μmol/
min/mL) and non-supplemented AD mouse (6.67 ± 0.67 
μmol/min/mL) (Figure 2(c)).
 DNA damage was determined by scoring the DNA based 
on its tail’s pattern. DNA was graded from score 0 to 4 with 
no damage (score 0), mild to moderate damage (score 1 
and 2) and extensive damage (score 3 and 4) (Figure 3(a)). 
DNA damage level was significantly increased (p<0.05) in 
non-supplemented AD mouse (14.04 ± 1.475%) compared 
to wild type mouse (9.96 ± 1.15%). Meanwhile, the 
increased DNA damage in the AD mouse was decreased 
significantly by TRF (3.47 ± 0.35%) and αT (3.07 ± 0.43%) 
supplementation (Figure 3(b)).
DISCUSSION
Multiple lines of evidence have shown that oxidative 
stress plays a critical role in the initiation and progression 
of AD (Wang et al. 2014). Oxidative stress can increase 
the production and aggregation of Aβ and promote 
FIGURE 1. Representative gels show the genotyping of (a) APPswe and (b) PS1dE9 genes. Transgenic
mouse is confirmed by the presence of APPswe gene band at 350bp and PS1dE9 gene at 608bp and 799bp
(a) (b)
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phosphorylation of tau protein, the hallmark of AD (Zhao & 
Zhao 2013). Aβ-induced oxidative imbalance may increase 
the levels of by-products such as malondialdehyde, carbonyl, 
8-hydroxyldeoxyguanosine and 8-hydroxylguanosine that 
lead to oxidation of lipid, protein, DNA and RNA. Defects 
in antioxidant defence mechanisms may cause increased 
oxidative stress and further facilitated Aβ depositions in 
transgenic mice with APP mutation (Zhao & Zhao 2013). 
APPswe/PS1dE9 mouse is an established model of AD 
that presented with Aβ deposition as early as 6 months old 
with abundant plaques mainly found in the hippocampus 
and cortex (Jankowsky et al. 2004; Lesuisse et al. 2001). 
Swedish mutations (K595N/M596L) increased the amount 
of Aβ produced by favouring processing through the beta-
secretase pathway that is well known can induce oxidative 
stress. Study performed by Zhang et al. (2012) found an 
elevation of MDA and protein carbonyl, while decreased 
level of antioxidant enzymes such as SOD and GSH-px in 
3.5 months old APPswe/PS1dE9 mouse compared to WT 
mouse. The antioxidant activities of tocotrienols have 
been linked to improve cognitive performance in animal 
studies. Supplementation of mixed tocotrienols (α-, β- and 
γ-tocotrienols) managed to reduce cognitive deficit in 
streptozotocin-induced diabetic rats by decreasing the level 
of brain oxidative stress (Kuhad et al. 2009). Meanwhile 
Taridi et al. (2014) have shown that TRF supplementation 
for 3 months was able to reverse the age-related cognitive 
impairments in aged rats. 
 SOD is an important part of cellular antioxidant defence 
system which catalyses the dismutation of superoxide 
anion to hydrogen peroxide and oxygen (Rodriguez et al. 
2004). Hydrogen peroxide was then decomposed to water 
by GPx or CAT. In the absence of antioxidant enzymes, 
hydrogen peroxide is converted to hydroxyl radical that 
causes oxidative damage to cellular macromolecules. 
Our results showed that AD mouse without vitamin E 
a p<0.05 compared with WT (control);
b p<0.05 compared with AD (control);
c p<0.05 compared with AD (αT);
d p<0.05 compared with AD (TRF)
FIGURE 2. Effects of TRF and αT supplementation on (a) SOD activity, 
(b) GPx activity and (c) CAT activity in mice erythrocytes  
Data is presented in mean ± SEM
(a)
(b)
(c)
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supplementation demonstrated a significant increase in 
the level of SOD activity compared to the wild type mice. 
The high level of SOD activity in AD mouse may be due to 
high level of oxidative stress thus triggers the antioxidant 
defence mechanisms. The increased in SOD activity in AD 
mouse was attenuated by supplementation of TRF and αT, 
suggesting that both vitamins act as potent antioxidant to 
scavenge free radicals which spare the activity of SOD in AD 
mouse. Consistent with our findings, De Leo et al. (1998) 
found that SOD activity was elevated in erythrocytes of AD 
patients. SOD activity was also increased in brain cortex 
of 3×Tg-AD transgenic mouse model of AD (Resende et 
al. 2008). On the other hand, meta-analysis by Schrag 
et al. (2013) found that SOD activity was unaffected in 
the erythrocyte of AD patients compared to age-matched 
controls. In contrast, SOD activity was lower in the frontal 
and temporal cortex of the brain (Marcus et al. 1998), in 
plasma and erythrocyte of AD patients compared with 
age-matched controls (Rinaldi et al. 2003). The effects of 
TRF on SOD activity in the pathogenesis and progression 
of AD were largely unknown. Other studies in human and 
ageing models showed that TRF has the ability to modulate 
the activity of SOD. TRF supplementation decreased SOD 
activity in senescent human diploid fibroblasts (Makpol 
et al. 2013), healthy adults with age above 50 years (Chin 
et al. 2011) and aged mice (Aliahmat et al. 2012). These 
findings point to a notion that antioxidant activity of TRF 
was likely accounted for the compensated decrease of SOD 
activity (Makpol et al. 2013) which potentially provide 
protection against oxidative stress in AD. 
 Previous studies on the activity of GPx in AD patients 
and animal models were rather controversial. Our results 
indicated that wild type and AD mouse had no difference 
in the level of erythrocyte GPx activity with or without TRF 
supplementation. Other studies reported that GPx activity 
was unchanged in erythrocyte (Perrin et al. 1990) and in 
frontal, temporal and cerebellar cortex (Marcus et al. 1998) 
of AD patients. Aliahmat et al. (2012) found no significant 
changes in aged mouse with supplementation of TRF. 
However, GPx activity was elevated in the hippocampus, 
amygdala and piriform cortex (Lovell et al. 1995) and 
serum (Padurariu et al. 2010) of AD patients and in the 
a p<0.05 compared with WT (control);
b p<0.05 compared with AD (control);
c p<0.05 compared with AD (αT);
d p<0.05 compared with AD (TRF)
FIGURE 3. (a) Examples of comet images from whole blood stained with ethidium bromide. 
DNA was graded from score 0 to 4 based on the severity of the damage and (b) Effects of TRF 
or αT supplementation on the level of DNA damage in AD mice 
Data is presented in mean ± SEM 
(a)
(b)
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cortex of 3×Tg-AD transgenic mouse model of AD (Resende 
et al. 2008) while GPx activity was decreased in plasma of 
AD patients (Rinaldi et al. 2003). Despite the actual effect 
of TRF on GPx activity in AD remains unclear, other studies 
have shown that TRF increased GPx activity in senescent 
human dermal fibroblasts (Makpol et al. 2013), healthy 
older adults (Chin et al. 2011) and aged rats (Taridi et al. 
2014). 
 Our data showed that CAT activity was unaffected by 
APPswe and PS1dE9 mutations in the AD mouse model. 
A meta-analysis has shown that blood CAT activity was 
unchanged in AD patients (Schrag et al. 2013). Others 
have shown CAT activity was higher in erythrocyte (Perrin 
et al. 1990) and in hippocampus (Lovell et al. 1995), 
while decreased in temporal cortex (Marcus et al. 1998) 
of AD patients. Our study found that TRF supplementation 
significantly increased CAT activity in AD mouse model. 
Other studies have shown that CAT activity was unaffected 
in HDFs treated with TRF (Makpol et al. 2013), in 
erythrocyte of aged rats supplemented with TRF (Aliahmat 
et al. 2012) and in healthy elderly adults supplemented 
with TRF (Chin et al. 2011). Although this was opposed 
to our findings, work by Taridi et al. (2014) showed TRF 
supplementation increased CAT activity in erythrocyte 
of aged rats. Overexpression of CAT in CAT/APP double 
transgenic mouse was able to increase lifespan, reduced 
Aβ deposition and brain oxidative DNA damage level (Mao 
et al. 2012), supporting the theory that TRF was able to 
provide protection against oxidative stress in AD. 
 Oxidative stress associated with AD appears to be 
associated with DNA strand breaks found in brain tissues 
of AD subjects (Feng & Wang 2012). Our data indicated 
that the level of DNA damage in the AD control mouse was 
significantly higher as compared to wild type mouse. This 
was in accordance to other findings where the level of DNA 
strand breaks was found to be elevated in cortex (Anderson 
et al. 1996; Mullaart et al. 1990), while 8-OHdG level 
was increased in lymphocyte (Mecocci et al. 2002) and 
brain (Lyras et al. 1997) of AD patients. APPswe/PS1dE9 
transgenic mouse model overexpressed amyloid-β thus 
induces high level of DNA damage (Jiao et al. 2012). Our 
study found that TRF and αT supplementation significantly 
reduced the level of DNA damage in AD mouse. This is 
supported by the findings by Nakashima et al. (2004) that 
supplementation of αT was able to decrease the level of 
oxidised DNA. TRF was reported to reduce DNA damage 
in human study and animal models. Supplementation of 
TRF has successfully reduced blood DNA damage in aged 
rats (Taridi et al. 2011). Increased DNA damage in rats that 
undergo exercise training protocol was reversed by the 
supplementation of TRF (Abd Hamid et al. 2011). TRF has 
also been shown to reduce DNA damage in the leukocyte 
of healthy older adults (Chin et al. 2008). 
CONCLUSION
In conclusion, TRF has the ability to modulate antioxidants 
system of an AD transgenic mouse model. The ability of 
TRF to suppress the SOD activity and reduce the level of 
DNA damage as well as increase CAT activity highlight 
the potential of TRF for future alternative treatment for 
Alzheimer’s disease. Further studies have to be carried 
out to determine the effect of TRF supplementation on 
cognitive performance and brain oxidative status in AD 
mouse which warrants better understanding on the role of 
TRF in the pathogenesis of AD and its progression.
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